China’s probe of infant formula prices and foreign drugmakers may mask a broader campaign for the NDRC to justify its own existence. Photo: AFP

Reform agenda puts China’s economic super agency under scrutiny

Behind China’s two investigations into irregular pricing of infant formula and pharmaceuticals announced this month is one powerful institution and its struggle for relevance as Beijing attempts a transition to a more consumption-led economy.